Trio Healthcare boosts leadership team

New appointments include chief executive, chief financial officer, chief technology officer, and non-executive director

UK ostomy specialist, Trio Healthcare, has bolstered its senior leadership team through a series of key appointments, including new chief executive, Chris Lane.

Lane will be stepping in for former chief executive, Lloyd Pearce, who will assume the role of chief technology officer.

Lane will be moving into the role having acted as Trio’s chief operating officer over the last two years and will drive forward the business’s commercial and manufacturing operations as it gears up for the global launch of its innovative product range, Genii.

The launch will significantly advance Trio’s share of the international ostomy products market, currently valued at $1.5billion.

In his new role, Pearce will oversee the company’s award-winning R&D team, having been fundamental to the development of Trio’s proprietary breathable silicone technology, Sil2.

The business has also promoted Helen Jennings from finance director to chief financial officer.

She assumes responsibilities from chief strategy officer, Spencer Kerry, who oversaw the completion of a circa $10m funding round from SWK Holdings (SWK) in July this year.

Kerry, in turn, will move into the role of non-executive director, advising on Trio’s rapid international expansion.

The appointments follow key international hires made by the company in April, when it welcomed Christian Stegle as business director for Asia Pacific, and Hussain Malkawi, business director for the Middle East.

Lane said: “It’s an incredibly-exciting time to be part of the Trio team, and I’m grateful for the support of the business as I assume the role of CEO.

“Lloyd has played a pivotal role in Trio’s growth over the last 15 years, and it is a natural next step for him to assume the new role of CTO, where he will continue to inspire our team to push boundaries in ostomy R&D.

“And I’m delighted also to welcome Helen into her role as CFO. Her experience and diligence places the company in very good hands.

“As we continue to grow rapidly and outpace our competition, our sights are firmly set on delivering our unique technology to a growing number of international markets.

“We have spent a number of months ensuring everything is in place for the successful launch of our new stoma bag range, in order to replicate the success it has already seen within the UK ostomy market.

“As ever, our commitment to improving the quality of life for those living with stomas by challenging the lack of innovation in the ostomy market is steadfast.”

Pearce adds: “It has been, and continues to be, an enormous pleasure and source of great pride to see Trio grow, and the company is well positioned for truly-transformational growth under Chris’s astute guidance.

“I am excited to oversee our portfolio of world-beating silicone technologies and explore future innovation opportunities as CTO, continuing to work alongside the very best in the industry.”

Companies